Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$155.22 - $162.74 $124,641 - $130,680
-803 Reduced 20.17%
3,178 $503 Million
Q4 2023

Jan 29, 2024

SELL
$145.6 - $158.88 $28,683 - $31,299
-197 Reduced 4.72%
3,981 $624 Million
Q3 2023

Oct 27, 2023

SELL
$155.75 - $174.48 $80,522 - $90,206
-517 Reduced 11.01%
4,178 $651 Million
Q2 2023

Aug 08, 2023

BUY
$154.35 - $166.11 $48,774 - $52,490
316 Added 7.22%
4,695 $777 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $96,823 - $115,546
-641 Reduced 12.77%
4,379 $679 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $804,204 - $902,545
5,020 New
5,020 $887 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $430B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Alpha Q Advisors LLC Portfolio

Follow Alpha Q Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Q Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Q Advisors LLC with notifications on news.